BIV201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BIV201, covering 2024-05-08 to 2024-05-08. Get the full timeline:
Most recent: Clinical Trial Update: A Study for Evaluation of BIV201 to Reduce Ascites and Complications in Patients With Cirrhosis and Refractory Ascites [Phase 2]